RYL up +2.04% percent right now. $RYL High is at 37.99 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
RYL up +2.04% percent right now. $RYL High is at 37.99 and the Low 37.30 with current volume of 672,605.

Recent News posted below.

RYL Ryland Group Recent Headline News

One Reason Hovnanian Enterprises (HOV) Stock Is Rising Today
at The Street - Mon Nov 10, 10:51AM CST
Hovnanian Enterprises (HOV) stock is up today as homebuilders get a boost from Toll Brothers' preliminary financial results and positive comments by Jim Cramer on "Squawk on the Street."
KB: 36.94 (-0.33), DHI: 23.44 (+0.31), RYL: 37.19 (+0.47), TOL: 33.11 (+0.89), HOV: 3.93 (+0.16)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Ryland Group Is Up 2.6% (RYL)
Comtex SmarTrend(R) - Mon Nov 10, 9:18AM CST
18 days ago, on October 23rd, 2014, Ryland Group (NYSE:RYL) reported its earnings. Analysts, on average, expected earnings of $0.80 per share on sales of $708.7 million. Ryland Group actually reported earnings of $0.85 per share on sales of $680.2 million, beating EPS estimates by $0.05 and missing revenue estimates by $28.5 million. Since the company's report, shares of Ryland Group have risen from $35.78 to $36.72, representing a gain of 2.6% in the past 18 days.
RYL: 37.19 (+0.47)

Homebuilders higher after early Toll Bros. results
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:08AM CST

DHI: 23.44 (+0.31), LEN: 45.29 (+0.75), RYL: 37.19 (+0.47), XHB: 31.91 (+0.09), ITB: 24.77 (+0.22), PHM: 20.29 (+0.33), KBH: 16.43 (+0.09), HOV: 3.93 (+0.16)

Ryland Group (RYL) Strong On High Relative Volume Today
at The Street - Mon Nov 10, 9:04AM CST
Trade-Ideas LLC identified Ryland Group (RYL) as a strong on high relative volume candidate
RYL: 37.19 (+0.47)

Ryland to Webcast Its Presentation at the UBS Building and Building Products Annual CEO Conference
Business Wire - Thu Nov 06, 9:00AM CST
The Ryland Group, Inc. (NYSE: RYL), will webcast its presentation at the UBS Building and Building Products Annual CEO Conference on Thursday, November 13, at 12:30 PM EST. A link to the presentation can be accessed by going to the Investor Relations sections of our website www.Ryland.com, and clicking on the Events & Presentations banner. A replay of this webcast will be archived on our site for 180 days following the presentation.
RYL: 37.19 (+0.47)

Housing Update Market: It's Getting Worse
Dave Kranzler - at Seeking Alpha - Thu Nov 06, 5:29AM CST

DHI: 23.44 (+0.31), LEN: 45.29 (+0.75), RYL: 37.19 (+0.47), PHM: 20.29 (+0.33), BZH: 19.30 (+0.74), KBH: 16.43 (+0.09), TOL: 33.11 (+0.89)

Ryland Homes Congratulates its 2014 SoCal Award-Winning Team Members From Melrose at Pavilion Park
Business Wire - Tue Nov 04, 12:00PM CST
Ryland Homes, a nationally recognized builder that has changed homebuyers' perspectives of Southern California living, is proud to congratulate its hard-working team members for being honored with a prestigious SoCal Award at the recent 2014 ceremony.
RYL: 37.19 (+0.47)

Ryland Homes Tampa Announces Three New Coming-Soon Communities
Business Wire - Wed Oct 29, 11:03AM CDT
Ryland Homes (NYSE:RYL) Tampa is expanding through three brand-new, beautiful communities offering homebuyers a choice of stunning lakefront homes, spacious townhomes and cozy villas in locations across the Tampa Bay area. Each community is slated to open in December 2014.
RYL: 37.19 (+0.47)

Three Things That Must Happen Before the Economy Gets Really Good
at The Street - Mon Oct 27, 5:00AM CDT
Last week’s housing data were pretty good. But easier credit and faster job growth will make things much better -- maybe pretty soon.
RYL: 37.19 (+0.47), PHM: 20.29 (+0.33)

New Homes Sales: September Report Confirms That The Data Is Unreliable
Dave Kranzler - at Seeking Alpha - Fri Oct 24, 1:33PM CDT

LEN: 45.29 (+0.75), RYL: 37.19 (+0.47), PHM: 20.29 (+0.33), BZH: 19.30 (+0.74), TOL: 33.11 (+0.89), HOV: 3.93 (+0.16)

New-Home Sales Hit Post-Bust High, And A Ceiling Too?
at Investor's Business Daily - Fri Oct 24, 12:36PM CDT
New-home sales set a new standard for volatility, as an August reading that was previously reported as an annualized 504,000 was revised down to 466,000. Other prior months were also revised down. So September's sales rose slightly, rather than...
DHI: 23.43 (+0.30), LEN: 45.29 (+0.75), RYL: 37.19 (+0.47), PHM: 20.29 (+0.33), KBH: 16.43 (+0.09)

Ryland Homes Introduces Las Vegas Area Homebuyers to Two Incredible New Communities
Business Wire - Fri Oct 24, 11:15AM CDT
Ryland Homes is thrilled to introduce homebuyers to two stunning new collections of spacious single-family homes. Arista in Henderson and Bristle Falls in Las Vegas both offer 5 innovative and flexible floorplans in expertly designed communities with spacious homesites. Homebuyers can get a firsthand look at what life in these communities will be like during the Grand Opening celebrations on Saturday, October 25th from 11am-5pm. Ryland's new 2-story single-family homes feature 2,203 - 2,752 sq. ft. of living space, up to 5 bedrooms, 3 baths, a 2-car garage and are priced from the mid $200's.
RYL: 37.19 (+0.47)

The Ryland Group's (RYL) CEO Larry Nicholson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 3:47PM CDT

RYL: 37.19 (+0.47)

Ryland Group (RYL) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 10:55AM CDT

RYL: 37.19 (+0.47)

Rising Home Prices Boost PulteGroup, Ryland In Q3
at Investor's Business Daily - Thu Oct 23, 10:36AM CDT
Higher home prices and a stronger U.S. economy propelled PulteGroup (PHM) to third-quarter earnings that edged Wall Street's expectations. The Atlanta-based homebuilder earned 37 cents a share, beating by a penny estimates of analysts polled by...
RYL: 37.19 (+0.47), PHM: 20.29 (+0.33)

Orders and prices higher at Ryland Group
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 9:23AM CDT

RYL: 37.19 (+0.47)

Ryland tops 3Q net income expectations
Automated Insights - Thu Oct 23, 7:21AM CDT
WESTLAKE VILLAGE, Calif. (AP) _ Ryland Group Inc. (RYL) on Thursday reported third-quarter profit of $48.5 million.
RYL: 37.19 (+0.47)

Ryland Group  beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 7:08AM CDT

RYL: 37.19 (+0.47)

Ryland Reports Results for the Third Quarter of 2014
Business Wire - Thu Oct 23, 7:03AM CDT
The Ryland Group, Inc. (NYSE: RYL) today announced results for its quarter ended September 30, 2014. Items of note included:
RYL: 37.19 (+0.47)

Why KB Home (KBH) Stock Is Higher Today
at The Street - Tue Oct 21, 1:41PM CDT
KB Home (KBH) and other home builder stocks are rising after the National Association of Realtors said existing home sales in the U.S. increased by 2.4% in September.
DHI: 23.43 (+0.30), RYL: 37.19 (+0.47), KBH: 16.42 (+0.08), HOV: 3.93 (+0.16)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading